Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy Transcript

Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
IEEE

Supervisor Synthesis Using Labeled Petri Nets for Forbidden State Specifications

Abstract: This research focuses on the forbidden state problem in the framework of labeled Petri nets (LPNs), i.e., to design a supervisor for a plant modeled by an LPN such that the closed-loop ...
IEEE

Periodic Phase Diagrams in Micromagnetics With an Eigenvalue Solver

Abstract: This work introduces an approach to compute the periodic phase diagram of micromagnetic systems by solving a periodic linearized Landau-Lifshitz–Gilbert (LLG) equation using an eigenvalue ...
gut.bmj

P120 Upadacitinib for moderate-to-severe ulcerative colitis: interim results from U-ACTIVATE phase III open-label extension

Introduction Upadacitinib (15 mg [UPA15] or 30 mg [UPA30] once daily) demonstrated efficacy vs placebo after 52 weeks (wks) of maintenance therapy in the U-ACHIEVE Maintenance study. 1 2 Methods This ...